Every few months, another notice appears in FDA or EMA databases: a drug has been withdrawn. Sometimes it’s contamination, sometimes deadly side effects. But rarely do you see headlines. The pattern is clear. A new pill is rushed to market under 'fast-track approval'. Years later, after billions in sales, regulators concede that patients were harmed. Vioxx, fen-phen, ranitidine — the list is long. Even more disturbing: many withdrawals are handled in silence. Buried PDFs on EMA’s site, obscure postings in the Federal Register. No front-page news, no accountability for executives who signed off on unsafe trials. This is not regulation. It’s damage control — protecting pharma reputations first, patients second. The public is told to 'trust the science', but behind the curtain, the science is bent to fit quarterly earnings. Truthloop will not let these disappear into archives. Drugwatch exists to track what regulators won’t: the human cost of corporate medicine.